Abstract Proliferation and differentiation of neural stem cells (NSCs) have a crucial role to ensure neurogenesis and gliogenesis in the mammalian brain throughout life. As there is growing evidence for the significance of metabolism in regulating cell fate, knowledge on the metabolic programs in NSCs and how they evolve during differentiation into somatic cells may provide novel therapeutic approaches to address brain diseases. In this work, we applied a quantitative analysis to assess how the central carbon metabolism evolves upon differentiation of NSCs into astrocytes. Murine embryonic stem cell (mESC)-derived NSCs and astrocytes were incubated with labelled [1-
Introduction
Neural stem cells (NSCs) are multipotent cells present in the developing brain that persist in restricted regions of postnatal and adult brains, where they continue to produce the three neural lineages: neurons, astrocytes and oligodendrocytes [18] . Astrocytes are the most abundant brain cells [22] , being involved in virtually every function of the central nervous system, including energy metabolism [28] , ionic homeostasis [32] and synaptic transmission [15, 33] . Importantly, glutamatergic and GABAergic neurotransmission processes are dependent on astrocytic metabolism for neurotransmitter replenishment [4] . Furthermore, astrocytes store brain energy currency in the form of glycogen [7] , and release substrates for neuronal oxidative phosphorylation [25] . Moreover, astrocytes have been suggested as contributors to neurodegenerative disorders by various mechanisms, including via metabolic dysfunction [27] , making them potential targets for novel strategies to treat brain disorders. Given their importance for brain function, the generation of astrocytes from NSCs has attracted much attention recently. It is known that NSCs and astrocytes share several phenotypic and functional features [12, 31] , but their metabolic programs have not been compared at a global metabolic flux level yet.
In vivo intracellular metabolic fluxes have been estimated using several mathematical frameworks. When metabolic steady-state can be assumed (i.e all fluxes and intracellular concentrations are approximately constant over time), 13 C-Metabolic flux analysis ( 13 C-MFA) is the most useful tool to provide a metabolic snapshot of cells [29, 30, 38] . Nuclear magnetic resonance (NMR) spectroscopy and/or mass spectrometry (MS) techniques are used to measure the incorporation of a 13 C label from medium nutrients into intracellular metabolites. A computational framework based on both metabolite and isotopomer balances is then used to integrate this data with experimentally determined uptake and secretion rates to estimate intracellular metabolic fluxes. This approach has been applied to study metabolic network operation and diagnosing of phenotypic perturbations in several biological systems [1, 10, 20, 21] , including primary astrocytic cultures [2] .
In this work, we present the first quantitative study of the metabolic programs during specification of astrocytes from NSCs. To obtain highly homogeneous non-proliferating astrocyte cultures, we have recently developed a protocol using pure and defined populations of mouse pluripotent stem cell-derived NSCs [16] . Exposure to BMP4 promoted astrocytic differentiation of these NSCs within 2 days. The resulting astrocytes expressed several positive astrocyte markers (GFAP, aquaporin-4, and GLT-1), showed negligible expression of the NSC marker nestin, and acquired innate immune functions [16] . Herein, NSCs and NSC-derived astrocytes were incubated with [1- 13 C]glucose, and the transient 13 C labelling profiles of intracellular metabolites were modelled by isotopically non-stationary 13 C-MFA [23] , identifying significantly different metabolic flux maps in each population.
Materials and Methods

Differentiation of NSCs and Astrocytes from Murine Embryonic Stem Cells
The murine embryonic stem cell (mESC) line CGR8 (07032901, Sigma) was used in this work for commitment to the neural lineage, as described in [16] . Briefly, for differentiation into neural stem cells (NSCs), cultures of mESCs were harvested with 0.05% trypsin, pelleted, and replated in N2B27-medium (1:1 Neurobasal-A and Advanced DMEM/F12, containing N2 & B27 supplements, 100 lM b-mercaptoethanol, 7.5 lg/mL insulin, and 50 lg/ mL bovine serum albumin). On day 7, the growth factors FGF2 (20 ng/mL) and EGF (20 ng/mL) were added. After about 8 to 12 passages of NSCs, homogeneous and aggregate-free cultures were obtained and used for differentiation into astrocytes using N2B27-medium supplemented with BMP4 (20 ng/mL). Cells were incubated at 37°C with 5% CO 2 .
Stable Isotope Cultures
For isotopic labelling, NSCs and astrocytes were cultured in 6-well plates with custom N2B27-medium without glucose and without glutamine, supplemented with 10 mM [1-13 C]glucose (Sigma-Aldrich, 297046) and 2 mM glutamine for NSCs, or without glutamine supplementation for astrocytes.
Sampling was performed immediately after label administration and then at 3 h, 12 h, and 24 h (Figure 1a ). Replicate samples of culture supernatants were collected, clarified (2009g for 10 min) and stored at -20°C for later extracellular metabolite analysis (see below). Upon removing the culture supernatants, cell monolayers were washed twice with ice-cold PBS to eliminate tracer amounts of extracellular metabolites, and the plates were placed on liquid nitrogen to rapidly stop metabolism. For intracellular metabolite extraction, 700 ll of ethanol 70% (v/v) were added to each well and the cells were detached using a cell scraper, followed by clarification (15 min at 20,0009g) and storage of the supernatants at -80°C until GC-MS analysis (see below). The pellets containing cellular material were stored at -20°C for protein quantification (see below). Additional wells seeded with NSCs and astrocytes were used to profile cell concentration and viability along the same sampling schedule.
Analysis of Extracellular Metabolites
Glucose and lactate concentrations in culture supernatants were measured with an automated YSI 7100 Multiparameter Neurochem Res (2017) 42:244-253 245 Bioanalytical System (Dayton, OH, USA). Amino acid concentrations were analyzed by HPLC using the Waters AccQ.Tag Amino Acid Analysis Method (Waters, Milford, MA) as described elsewhere [9] . The extracellular concentrations of citrate and pyruvate were determined by 1 H-NMR spectroscopy using a 500 MHz Avance spectrometer (Bruker, Billerica, MA) with a 5 mm QXI inversed probe. Spectra were recorded at 25°C using a NOESY-based pulse sequence with water pre-saturation, performing 256 scans with 4 s acquisition time, 2 s relaxation delay and 100 ms mixing time. DSS-d6 (Sigma Aldrich, St. Louis, MO; USA) was used as internal standard for metabolite quantification in all samples. In order to obtain a similar pH between samples, they were mixed with phosphate buffer (pH 7.4) prepared in D 2 O at a 2:1 ratio. Before spectra acquisition, the spectrometer was calibrated by determining the 908 pulse and the water chemical shift centre of each sample. Each spectrum was phased, baseline corrected and integrated using the Chenomx NMR Suite 8.0 (Chenomx Inc., Edmonton, Alberta, Canada) software.
Cell Concentration, Viability and Protein Content Measurements
Total cell concentration was determined after trypsinization using the haemocytometer counting method. Cell viability was measured by quantification of resazurin reduction. Resazurin was added to the medium at 1 lg/ml for 30 min at 37°C. Resazurin reduction (560 nm excitation, 590 nm emission) was measured as cell viability parameter using the InfiniteÒ 200 PRO multimode reader (Tecan). The protein content was measured in cell pellets after metabolite extraction. The cell pellets were lysed in 2% sodium dodecyl sulfate (SDS) (in 125 mM Trizma, 10% glycerol) and the protein quantified with the Pierce TM BCA Protein Assay Kit (Thermo Scientific), according to the manufacturer's protocol.
Quantification of Intracellular Mass Isotopomer Distributions by GC2MS
For analysis of 13 C enrichment in lactate, amino acids (alanine, aspartate, glutamate, and glutamine), and TCA cycle intermediates (citrate, fumarate, succinate and malate), lyophilized metabolite extracts were dissolved in 0.01 M HCl followed by pH adjustment to pH\2 with 6 M HCl. The samples were then dried under atmospheric air (50°C), and the metabolites extracted in multiple steps into an organic phase of ethanol and benzene. Afterwards, the samples were lyophilized again and derivatized with N-Methyl-N-(tButyldimethylsilyl)trifluoroacetamide (MTBSTFA) ? 1% t-butyldimethylchlorosilane (TBDMSCI). The glycolytic intermediates phosphoenolpyruvate (PEP) and 3-phosphoglycerate (3PG) were analyzed using a similar protocol to that described in [14] . Briefly, lyophilized metabolite extracts were dissolved in methanol and dried under atmospheric air (50°C). The metabolites were then extracted with toluene and dried again under atmospheric air (50°C). Derivatization was performed using a mixture of N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) ? 1% trimethylchlorosilane and acetonitrile.
The mass isotopomer distributions of the derivatized metabolites were analyzed on an Agilent 6890 gas chromatographer equipped with a capillary column (WCOT fused silica 25 mm 9 0.25 mm ID, 0.25 lm film thickness, VF-1ms, Varian), and connected to an Agilent 5975B mass spectrometer with electron impact ionization (Agilent Technologies, Palo Alto, CA, USA). All ions (M, M1, Mm, where M is the mass/charge ratio of the unlabelled derivatized fragment and m is the number of labelled carbons) were measured by spectra integration using the MassHunter software (Agilent Technologies, Palo Alto, CA, USA) and corrected for natural 13 C abundance using non-enriched standards [35] .
Metabolic Flux Determination
Estimation of metabolic fluxes of NSCs and astrocytes was performed by isotopic non-stationary 13 C-MFA. Our experimental data was comprised of exchanged rates and corrected mass isotopomer distributions of intracellular metabolites. The extracellular rates were calculated by linear fitting of extracellular metabolite profiles (assuming metabolic steady state throughout the labeling experiment) and normalized to protein content per well. The reaction network used for flux estimation included the main pathways of central carbon metabolism: glycolysis, pentose phosphate pathway, tricarboxylic acid cycle and amino acids metabolism. Table 1 lists all metabolic reactions and carbon atom transitions (balanced and unbalanced metabolite pools are also identified). Since cell concentration and protein content were maintained during the labelling experiment, reactions for biomass formation were omitted in the network. Extracellular transport reactions were considered reversible to allow equilibration with extracellular pools, except for essential amino acids and glucose.
Non-stationary 13 C-MFA was performed using the publicly available software package INCA [40] , which implements the elementary metabolite units framework [41] . Briefly, fluxes are estimated by minimizing the variance-weighted sum of squared residuals (SSR) between experimental measurements and model predictions using least-squares regression. At least 10 restarts with random initial values were performed to find a global optimum [11] . At convergence, the obtained solution was subject to a qui-square statistical test to evaluate goodness-of-fit. 95% confidence intervals of estimated fluxes were calculated through the parameter continuation method described by [3] . The number of degrees of freedom (n-p) associated with each flux estimation solution is 86 and 73 for NSCs and astrocytes, respectively (see supplementary material, Table S3 ). This means that in each case the number of independent measurements n (MIDs and extracellular fluxes) is superior to the number of free parameters p that were estimated (pools and unconstrained fluxes). A redundancy analysis is automatically performed during flux estimation by INCA, as described in [3] . Data overfitting was avoided by minimizing the number of metabolic reactions up to that necessary to accurately represent cellular carbon flow and satisfactorily simulate the data (i.e. intracellular compartmentation was considered only for pyruvate and no dilution fluxes or other pseudo-fluxes were used).
Results and Discussion
To study the metabolic modulations occurring during differentiation of mESC-derived NSCs to astrocytes, adherent monolayers of either fully-differentiated astrocytes or of NSCs were incubated with [1-
13 C]glucose. Samples from the culture supernatant and cell extracts were collected during 24 h (Figure 1a) . During this period, cell viability was always above 90%, and the exact protein amounts and cell number were determined for each individual dish used in the fluxomics study (data not shown). Astrocytes are larger in size when comparing to NSCs; they had on 
Modulation of Consumption and Production Rates During Astrocytic Differentiation
Analysis of changes in supernatant composition of NSCs indicated a lactate production to glucose consumption ratio of approximately 1 (Figure 1b) . Such high glycolytic metabolism in spite of oxygen availability is common to many stem cells [13, 42] and has been reported in proliferating NSCs [8] . It allows more metabolic intermediates to be available for the biosynthesis of cellular building blocks, which are required for proliferation [34] . Upon differentiation of NSCs into astrocytes, the glucose consumption decreased 1.5-fold on a per cell basis (2.5-fold on a per mg of protein basis; Figure 1b) . We calculated the consumption/production rates on a per cell and on a per mg of protein basis (Figure 1b , c) because both data normalizations are commonly found in brain metabolic studies and/or differentiation studies. Owing to the differences in cell size between NSCs and astrocytes, data interpretation is affected by the normalization method; for instance, while lactate production slightly decreases (13%) on a per mg of protein basis, it is 1.5-fold upregulated on a per cell basis upon differentiation. Nevertheless, the downregulation of glucose consumption was not matched by a proportional decrease in lactate production upon astrocytic differentiation, resulting in an even higher lactate production to glucose consumption ratio (close to 2). This extremely high glycolytic metabolism has been previously reported in primary cultures of cortical astrocytes (e.g. [2, 6] ). Striking differences between NSCs and astrocytes were also observed in the specific transport rates of some amino and organic acids (Figure 1c , Table S1 ). NSCs consumed glutamine at a high rate (10% of the glucose uptake rate) and, as opposed to astrocytes, cannot survive in glutaminefree medium (data not shown). Yeo et al. had already demonstrated the importance of the glutaminolysis pathway for long-term maintenance of NSCs [39] . Our comparative study showed that the NSC glutamine dependence is no longer present after its differentiation into astrocytes. NSC-derived astrocytes secreted glutamine (the rate was higher when cultured in glutamine-free medium), showing that even in the absence of neurons, these cells are able to recapitulate an important feature of the glutamate-glutamine cycle between neurons and astrocytes in the brain [5, 19] . Noteworthy, astrocytes took up glutamate from the medium at a similar rate of glutamine secretion (Table S1 ).
Another significant difference observed between these cell types was the upregulation of the pyruvate uptake rate upon astrocytic differentiation (3.6-fold on a per cell basis). Finally, astrocytes released citrate to the medium, while this metabolite was not detected in the medium of NSC cultures. Citrate secretion has been observed in primary cultures of astrocytes, but the reason is not entirely understood [36, 37, 43] .
Intracellular 13 C-labelling in NSCs and Astrocytes
After label administration, the fraction of [1-13 C]glucose measured intracellularly by GC-MS was 87% in NSCs and 84% in astrocytes. In both cell populations, the label enrichment of the glycolytic intermediates 3PG and PEP reached values over 40%, showing conservation of the 13 C label coming from glucose ( Figure 2 ). Since the first carbon of glucose is lost as CO 2 in the oxidative branch of the PPP, these results indicate that the non-oxidative PPP branch had low activity in both cell populations. Overall, the label enrichment in lactate, alanine, TCA cycle intermediates and related amino acids was lower than in glycolytic metabolites, indicating the contribution of other carbon sources (Figure 2 ). Despite the similarities, several differences emerged in the intracellular labelling patterns of NSCs and astrocytes. Firstly, isotopic steady-state was achieved for most metabolites in NSCs within 24 h, but not in astrocytes (Figures 3 and 4) , in agreement with the downregulation of astrocytic glucose consumption. The largest difference in the rate of 13 C incorporation between both populations was observed for the lactate pool at 12 h post label addition. The M1 isotopomer abundance was 11% in NSCs while it was only 3% in astrocytes. The higher consumption of (unlabeled) pyruvate from the medium by astrocytes may have contributed to the slower labelling of the astrocytic lactate pool. Moreover, NSCs displayed higher labelling in the citrate (38% vs. 30%) and succinate (8% vs. 4%) pools compared with astrocytes, but this difference was not propagated throughout the TCA cycle. In fact, the opposite result was observed for the malate pool, which was consistently more highly 13 C enriched in astrocytes at 12 h and 24 h after label addition. Moreover, succinate was less labeled than fumarate (57% less in NSCs and 71% less in astrocytic populations), which suggests additional routes of label entry into the TCA cycle, and at the same time suggests that succinate dehydrogenase (SucD) has limited reverse Table S2 activity. Finally, significant enrichment in intracellular glutamine was observed in astrocytes but not in NSCs, consistent with the measured glutamine secretion and consumption rates, respectively. However, when cultured in glutamine-free media, NSCs also incorporated significant 13 C from glucose into glutamine despite the viability loss, indicating glutamine synthetase (GS) activity (data not shown).
Fluxome Rearrangements During Astrocytic Differentiation of NSCs
Using isotopic non-stationary 13 C-MFA, metabolic fluxes were estimated for each cell type by integrating the timeprofiles of the mass isotopomer distributions (Figures 3, 4 ) with extracellular transport rates (Table S1 ) in a metabolic network model (Table 1) . Reasonably good fits were obtained for all metabolites in both cultures (Figures 3, 4) . All estimated fluxes and associated 95% confidence intervals are provided as Supporting Information (Table S3) .
For a global comparison of metabolic differences between NSCs and astrocytes, metabolic flux ratios were calculated for fluxes with finite lower and upper confidence interval bounds which exclude the value zero (Figure 5a ). Generally, NSCs displayed a higher metabolic flux in central carbon metabolism compared with astrocytes, including glycolysis (1.7-fold) and the TCA cycle (e.g. 19.4-fold higher citrate synthase flux). A detailed view of these differences can be observed in Fig. 5b , where the thickness and color of arrows reflect absolute flux values. These flux maps show that the activity of the PPP remained lower than 6% of the corresponding glycolytic flux in both cell populations. Half of the cytosolic pyruvate was converted to mitochondrial pyruvate in NSCs, while in astrocytes most of the cytosolic pyruvate was diverted to lactate secretion, consistent with the measured extracellular rates. In mitochondria, the majority of pyruvate in NSCs entered the TCA cycle by conversion to Acetyl-CoA (AcCoA) through pyruvate dehydrogenase activity (PDH; 318.0 nmol/h/10 6 cell), and the rest was carboxylated to oxaloacetate (OAC) (PC; 57.7 nmol/h/10 6 cell), resulting in a PC/PDH ratio of 0.18. On the other hand, astrocytes metabolization of mitochondrial pyruvate through PC was 4.3-fold higher (39.3 nmol/h/10 6 cell) than through PDH (9.1 nmol/h/10 6 cell). This anaplerotic metabolization of pyruvate in astrocytes contributed to support glutamine and citrate secretion. In contrast, glutamine was taken up from the medium by NSCs and metabolized to citrate via reductive carboxylation of alpha-ketoglutarate (AKG). The importance of this metabolic route was first identified in Table S3 for exact flux values and associated 95% confidence intervals) Neurochem Res (2017) 42:244-253 251 cancer cell cultures to support lipogenesis [20] , and a recent study suggests its activity also in human NSCs [24] . Although not pointed out by the authors, the prominent abundance of citrate M5 isotopomer upon incubation with [U- 13 C]glutamine is indicative of reductive carboxylation of glutamine-derived AKG. This reaction involves addition of an unlabelled carbon by isocitrate dehydrogenase (IDH) acting in reverse relative to the canonical oxidative TCA cycle, which produces citrate M4 from [U-
13 C]glutamine. In line with these results, [17] showed that de novo lipogenesis is important for NSCs proliferation. These cells have high enzymatic activity of fatty acid synthase (Fasn) and the inhibition of Fasn led to a significant reduction in proliferation.
Finally, a net flux of malate formation from OAC was estimated in both cell populations, which was then recycled back to pyruvate by malic enzyme (ME). Regardless of the total pyruvate flux that enters the TCA cycle, pyruvate cycling becomes rather important through the activity of ME and PC to balance TCA cycle activity and biosynthesis efflux in both NSCs and astrocytes.
Conclusion
A deeper understanding of the metabolic circuits in NSCs and how they evolve during differentiation may provide novel approaches for reactivating astrogenesis and neurogenesis to treat neurodegenerative diseases. Herein, we aimed at assessing the alterations in central carbon metabolism associated with the differentiation of NSCs into astrocytes using non-stationary 13 C-MFA. This is the first study in which a comparison of metabolic fluxes between these cell populations was performed, highlighting significant differences at the level of glycolysis, TCA cycle and amino acids metabolism. Specifically, astrocytic differentiation is followed by a downregulation of glucose consumption, but astrocytes keep an even higher lactate production to glucose consumption ratio than NSCs. Moreover, NSCs generated citrate by reductive carboxylation of AKG and channeled it towards cytosolic AcCoA formation, a precursor for fatty acid biosynthesis; in turn, the TCA cycle of astrocytes was rewired to support citrate and glutamine secretion, both metabolic features typically reported in primary astrocytic cultures. While the [1-
13 C]-glucose tracer used in this study provided a first overview of central carbon metabolism in this compelling biological setting, parallel experiments with other labeled substrates should be performed to specifically probe some of the identified metabolic features. For instance, [U- 13 C]glutamine could be used to confirm the prominent reductive carboxylation flux in NSCs. Due to its power to resolve intracellular fluxes, we expect the multiplication of 13 C-MFA studies of neural metabolism in the future.
